MOLP-2-Luc人多發(fā)性骨髓瘤熒光素酶穩(wěn)定表達(dá)細(xì)胞株NTCC? human multiple myeloma cell line BioVector NTCC保藏中心
- 價 格:¥799865
- 貨 號:BioVector?-MOLP-2-Luc
- 產(chǎn) 地:北京
- BioVector NTCC典型培養(yǎng)物保藏中心
- 聯(lián)系人:Dr.Xu, Biovector NTCC Inc.
電話:400-800-2947 工作微信:1843439339 (QQ同號)
手機:18901268599
地址:北京
- 已注冊
BioVector? NTCC? MOLP-2-Luc人多發(fā)性骨髓瘤熒光素酶穩(wěn)定表達(dá)細(xì)胞株NTCC? human multiple myeloma cell line
基本信息
名稱: MOLP-2-Luc NTCC? cell line
來源細(xì)胞系: MOLP-2(人多發(fā)性骨髓瘤細(xì)胞系)
物種: Homo sapiens(人)
類型: B 細(xì)胞樣、懸浮生長的腫瘤細(xì)胞
改造: 穩(wěn)定表達(dá)螢光素酶(Luciferase),用于體內(nèi)/體外生物發(fā)光成像
主要應(yīng)用
多發(fā)性骨髓瘤機制研究
藥物篩選與敏感性評價
動物實驗中的腫瘤負(fù)荷實時成像(BLI)
細(xì)胞信號通路與腫瘤微環(huán)境研究
生長特性(高層級描述)
生長方式: 懸浮
倍增時間: 中等速度
表型特征: 高度表達(dá)骨髓瘤相關(guān)標(biāo)記;攜帶可測量的生物發(fā)光信號
發(fā)光特性: 適合進(jìn)行熒光素底物誘導(dǎo)的原位發(fā)光檢測
生物安全信息
生物安全等級: 一般為 BSL-2(因有人源與轉(zhuǎn)基因成分,具體依賴機構(gòu)規(guī)定)
風(fēng)險提示: 作為腫瘤細(xì)胞株,需遵守標(biāo)準(zhǔn)細(xì)胞培養(yǎng)安全規(guī)范
質(zhì)量控制(依供應(yīng)商而定)
真菌/細(xì)菌/支原體檢測
發(fā)光信號穩(wěn)定性檢測
細(xì)胞身份驗證(STR 分析)
凍存與復(fù)蘇活力檢測
BioVector NTCC質(zhì)粒載體菌株細(xì)胞蛋白抗體基因保藏中心
電話:400-800-2947
工作QQ/微信同號:1843439339
網(wǎng)址 www.nedfriskphoto.com
General Information
Name: MOLP-2-Luc NTCC? human multiple myeloma cell line
Parent Line: MOLP-2 (human multiple myeloma cell line)
Modification: Stably transduced to express firefly luciferase (Luc)
Species: Human (Homo sapiens)
Disease Origin: Plasma-cell leukemia / multiple myeloma
Cell Type: Suspension; malignant plasma cells
Applications
In vivo bioluminescence imaging (BLI) models of multiple myeloma
Drug efficacy screening using luminescence readouts
Tumor growth tracking in animal studies
Mechanistic studies of myeloma progression and plasma-cell biology
Key Features
Stable luciferase expression enables non-invasive quantification of viable cell numbers
Derived from a human hematologic malignancy, retaining myeloma-related markers
Suitable for xenograft models commonly used in cancer-research pipelines
Biological Characteristics (High-Level)
Morphology: Non-adherent, spherical plasma-like cells
Growth Mode: Suspension
Doubling Time: Consistent with malignant B-cell lines (varies by provider)
Markers (parent line):
CD38?, CD138? typical of plasma cells
Immunoglobulin-producing phenotype
Genomic/Protein Modification:
Firefly luciferase integrated for luminescence assays
Biosafety & Handling
Biosafety Level: Typically BSL-2 (human cancer cell line)
Local institutional biosafety guidelines may differ
Hazards: Human-derived, malignant; treat as potentially infectious material
Standard PPE and biological-safety procedures recommended at all times
Authentication
Parent line originated from a multiple myeloma patient
Vendors usually provide:
STR profiling
Luciferase activity confirmation
Mycoplasma testing
Quality Control Notes (vendor-dependent)
Authentication of luciferase expression
Viability ≥ provider-specified threshold
Sterility panel: bacteria, fungi, mycoplasma
BioVector NTCC質(zhì)粒載體菌株細(xì)胞蛋白抗體基因保藏中心
電話:400-800-2947
工作QQ/微信同號:1843439339
網(wǎng)址 www.nedfriskphoto.com
Supplier來源:BioVector NTCC Inc.
Email: [email protected]
Website網(wǎng)址: http://www.nedfriskphoto.com
基本信息
名稱: MOLP-2-Luc NTCC? cell line
來源細(xì)胞系: MOLP-2(人多發(fā)性骨髓瘤細(xì)胞系)
物種: Homo sapiens(人)
類型: B 細(xì)胞樣、懸浮生長的腫瘤細(xì)胞
改造: 穩(wěn)定表達(dá)螢光素酶(Luciferase),用于體內(nèi)/體外生物發(fā)光成像
主要應(yīng)用
多發(fā)性骨髓瘤機制研究
藥物篩選與敏感性評價
動物實驗中的腫瘤負(fù)荷實時成像(BLI)
細(xì)胞信號通路與腫瘤微環(huán)境研究
生長特性(高層級描述)
生長方式: 懸浮
倍增時間: 中等速度
表型特征: 高度表達(dá)骨髓瘤相關(guān)標(biāo)記;攜帶可測量的生物發(fā)光信號
發(fā)光特性: 適合進(jìn)行熒光素底物誘導(dǎo)的原位發(fā)光檢測
生物安全信息
生物安全等級: 一般為 BSL-2(因有人源與轉(zhuǎn)基因成分,具體依賴機構(gòu)規(guī)定)
風(fēng)險提示: 作為腫瘤細(xì)胞株,需遵守標(biāo)準(zhǔn)細(xì)胞培養(yǎng)安全規(guī)范
質(zhì)量控制(依供應(yīng)商而定)
真菌/細(xì)菌/支原體檢測
發(fā)光信號穩(wěn)定性檢測
細(xì)胞身份驗證(STR 分析)
凍存與復(fù)蘇活力檢測
BioVector NTCC質(zhì)粒載體菌株細(xì)胞蛋白抗體基因保藏中心
電話:400-800-2947
工作QQ/微信同號:1843439339
網(wǎng)址 www.nedfriskphoto.com
General Information
Name: MOLP-2-Luc NTCC? human multiple myeloma cell line
Parent Line: MOLP-2 (human multiple myeloma cell line)
Modification: Stably transduced to express firefly luciferase (Luc)
Species: Human (Homo sapiens)
Disease Origin: Plasma-cell leukemia / multiple myeloma
Cell Type: Suspension; malignant plasma cells
Applications
In vivo bioluminescence imaging (BLI) models of multiple myeloma
Drug efficacy screening using luminescence readouts
Tumor growth tracking in animal studies
Mechanistic studies of myeloma progression and plasma-cell biology
Key Features
Stable luciferase expression enables non-invasive quantification of viable cell numbers
Derived from a human hematologic malignancy, retaining myeloma-related markers
Suitable for xenograft models commonly used in cancer-research pipelines
Biological Characteristics (High-Level)
Morphology: Non-adherent, spherical plasma-like cells
Growth Mode: Suspension
Doubling Time: Consistent with malignant B-cell lines (varies by provider)
Markers (parent line):
CD38?, CD138? typical of plasma cells
Immunoglobulin-producing phenotype
Genomic/Protein Modification:
Firefly luciferase integrated for luminescence assays
Biosafety & Handling
Biosafety Level: Typically BSL-2 (human cancer cell line)
Local institutional biosafety guidelines may differ
Hazards: Human-derived, malignant; treat as potentially infectious material
Standard PPE and biological-safety procedures recommended at all times
Authentication
Parent line originated from a multiple myeloma patient
Vendors usually provide:
STR profiling
Luciferase activity confirmation
Mycoplasma testing
Quality Control Notes (vendor-dependent)
Authentication of luciferase expression
Viability ≥ provider-specified threshold
Sterility panel: bacteria, fungi, mycoplasma
BioVector NTCC質(zhì)粒載體菌株細(xì)胞蛋白抗體基因保藏中心
電話:400-800-2947
工作QQ/微信同號:1843439339
網(wǎng)址 www.nedfriskphoto.com
Supplier來源:BioVector NTCC Inc.
Email: [email protected]
Website網(wǎng)址: http://www.nedfriskphoto.com
您正在向 biovector.net 發(fā)送關(guān)于產(chǎn)品 MOLP-2-Luc人多發(fā)性骨髓瘤熒光素酶穩(wěn)定表達(dá)細(xì)胞株NTCC? human multiple myeloma cell line BioVector NTCC保藏中心 的詢問
- 公告/新聞




